Low-Grade Inflammation, Oxidative Stress and Risk of Invasive Post-Menopausal Breast Cancer - A Nested Case-Control Study from the Malmö Diet and Cancer Cohort
暂无分享,去创建一个
B. Hedblad | G. Engström | B. Gullberg | J. Nilsson | G. N. Fredrikson | U. Ericson | S. Borgquist | J. A. Dias | E. Wirfält
[1] B. Hedblad,et al. Plasma variation and reproducibility of oxidized LDL-cholesterol and low-grade inflammation biomarkers among participants of the Malmö Diet and Cancer cohort , 2016, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[2] S. Rubin,et al. Chronic inflammation and risk of colorectal and other obesity‐related cancers: The health, aging and body composition study , 2016, International journal of cancer.
[3] D. Leroith,et al. Metabolic Syndrome, Type 2 Diabetes, and Cancer: Epidemiology and Potential Mechanisms. , 2015, Handbook of experimental pharmacology.
[4] H. Ni,et al. Serum Lipids and Breast Cancer Risk: A Meta-Analysis of Prospective Cohort Studies , 2015, PloS one.
[5] J. Roth,et al. The transcription factor nuclear factor interleukin 6 mediates pro- and anti-inflammatory responses during LPS-induced systemic inflammation in mice , 2015, Brain, Behavior, and Immunity.
[6] D. Greenwood,et al. Circulating C-Reactive Protein and Breast Cancer Risk—Systematic Literature Review and Meta-analysis of Prospective Cohort Studies , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[7] M. Touvier,et al. Cholesterol and breast cancer risk: a systematic review and meta-analysis of prospective studies , 2015, British Journal of Nutrition.
[8] I. McInnes,et al. Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases , 2015, Pharmacological Reviews.
[9] D. Khismatullin,et al. Oxidized Low-Density Lipoprotein Contributes to Atherogenesis via Co-activation of Macrophages and Mast Cells , 2015, PloS one.
[10] S. Mousa,et al. Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases , 2015, Critical reviews in clinical laboratory sciences.
[11] J. Morales-Montor,et al. The role of cytokines in breast cancer development and progression. , 2015, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[12] T. Mukherjee,et al. Mechanistic insight of drug resistance with special focus on iron in estrogen receptor positive breast cancer. , 2014, Current pharmaceutical biotechnology.
[13] C. Madeddu,et al. Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer , 2014, Journal of cellular and molecular medicine.
[14] M. Paesmans,et al. Systematic review about breast cancer incidence in relation to hormone replacement therapy use , 2014, Climacteric : the journal of the International Menopause Society.
[15] I. Romieu,et al. Female breast cancer and alcohol consumption: a review of the literature. , 2014, American journal of preventive medicine.
[16] Bhanu P. Jena,et al. Journal of Cellular and Molecular Medicine , 2014, Journal of Cellular and Molecular Medicine.
[17] Hisashi Adachi,et al. Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.
[18] B. Hedblad,et al. Plasma S100A8/A9 Correlates With Blood Neutrophil Counts, Traditional Risk Factors, and Cardiovascular Disease in Middle-Aged Healthy Individuals , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[19] S. Sinha,et al. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets. , 2013, Cytokine & growth factor reviews.
[20] E. Simpson,et al. Obesity and breast cancer: role of inflammation and aromatase. , 2013, Journal of molecular endocrinology.
[21] S. Su,et al. A critical role for interleukin-1β in the progression of autoimmune diseases. , 2013, International immunopharmacology.
[22] D. Rose,et al. The Obesity-Inflammation-Eicosanoid Axis in Breast Cancer , 2013, Journal of Mammary Gland Biology and Neoplasia.
[23] Gemma A. Figtree,et al. Biological markers of oxidative stress: Applications to cardiovascular research and practice☆ , 2013, Redox biology.
[24] J. Chae,et al. Effect of age on atherogenicity of LDL and inflammatory markers in healthy women. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[25] C. Hudis,et al. Molecular Pathways: Adipose Inflammation as a Mediator of Obesity-Associated Cancer , 2013, Clinical Cancer Research.
[26] M. Dowsett,et al. Sex hormones and breast cancer risk and prognosis. , 2013, Breast.
[27] P. Hojman,et al. The role of intratumoral and systemic IL-6 in breast cancer , 2013, Breast Cancer Research and Treatment.
[28] E. Simpson,et al. Minireview: Obesity and breast cancer: a tale of inflammation and dysregulated metabolism. , 2013, Molecular endocrinology.
[29] J. Slingerland,et al. Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. , 2013, Annual review of medicine.
[30] J. Stevens,et al. The Atherosclerosis Risk in Communities Study , 2013 .
[31] J. Carvalho,et al. Molecular link mechanisms between inflammation and cancer. , 2012, Current pharmaceutical design.
[32] O. Melander,et al. Incidence of Coronary Events and Case Fatality Rate in Relation to Blood Lymphocyte and Neutrophil Counts , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[33] 廣畑 富雄,et al. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective , 2007 .
[34] S. Hulley. The US National Cholesterol Education Program , 2012, Drugs.
[35] N. Rothman,et al. Intra-individual variability over time in serum cytokine levels among participants in the prostate, lung, colorectal, and ovarian cancer screening Trial. , 2011, Cytokine.
[36] M. Karin,et al. Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage , 2011, Annals of the rheumatic diseases.
[37] T. Meshel,et al. Inflammatory mediators in breast cancer: Coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition , 2011, BMC Cancer.
[38] D Goldberg,et al. Critical Reviews in Clinical Laboratory Sciences , 2010, Critical reviews in clinical laboratory sciences.
[39] M. Karin,et al. Inflammation and oncogenesis: a vicious connection. , 2010, Current opinion in genetics & development.
[40] Wei Liu,et al. Oxidized low-density lipoproteins upregulate proline oxidase to initiate ROS-dependent autophagy , 2009, Carcinogenesis.
[41] G. Berglund,et al. Ability of physical activity measurements to assess health-related risks , 2009, European Journal of Clinical Nutrition.
[42] P. Allavena,et al. Cellular and molecular pathways linking inflammation and cancer. , 2009, Immunobiology.
[43] T. Stulnig,et al. Obesity, Inflammation, and Insulin Resistance – A Mini-Review , 2009, Gerontology.
[44] G. Z. Rocha,et al. Epidemiological and molecular mechanisms aspects linking obesity and cancer. , 2009, Arquivos brasileiros de endocrinologia e metabologia.
[45] K. Jirström,et al. Anthropometric factors in relation to different tumor biological subgroups of postmenopausal breast cancer , 2009, International journal of cancer.
[46] Alberto Mantovani,et al. Cytokines as a key component of cancer-related inflammation. , 2008, Cytokine.
[47] P. Allavena,et al. Pathways connecting inflammation and cancer. , 2008, Current opinion in genetics & development.
[48] E. Stathopoulou,et al. Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer. , 2007, Clinical biochemistry.
[49] W. Willett,et al. Adult height, age at attained height, and incidence of breast cancer in premenopausal women , 2006, International journal of cancer.
[50] A. Nicolini,et al. Cytokines in breast cancer. , 2006, Cytokine & growth factor reviews.
[51] Juan Tang,et al. TNF-alpha promotes Doxorubicin-induced cell apoptosis and anti-cancer effect through downregulation of p21 in p53-deficient tumor cells. , 2005, Biochemical and biophysical research communications.
[52] Imran Awan,et al. Leukocyte count and coronary heart disease: implications for risk assessment. , 2004, Journal of the American College of Cardiology.
[53] A. Tamakoshi,et al. Serum oxidized low-density lipoprotein levels and risk of colorectal cancer: a case-control study nested in the Japan Collaborative Cohort Study. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[54] Graham A Colditz,et al. Risk factors for breast cancer according to estrogen and progesterone receptor status. , 2004, Journal of the National Cancer Institute.
[55] R. Krajcik,et al. No Association between Serum Levels of Tumor Necrosis Factor-α (TNF-α) or the Soluble Receptors sTNFR1 and sTNFR2 and Breast Cancer Risk , 2003 .
[56] J. Pankow,et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. , 2003, Diabetes.
[57] G. Berglund,et al. Identification of Immune Responses Against Aldehyde-Modified Peptide Sequences in ApoB Associated With Cardiovascular Disease , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[58] P. Ridker. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. , 2003, Circulation.
[59] G. Berglund,et al. A prospective study of adiposity and postmenopausal breast cancer risk: The Malmö diet and cancer study , 2003, International journal of cancer.
[60] P. Libby. Inflammation in atherosclerosis , 2002, Nature.
[61] M. Lindholm,et al. Inflammation and cholesterol , 2002 .
[62] A. Purohit,et al. The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer , 2002, Breast Cancer Research.
[63] G. Berglund,et al. The Malmö diet and cancer study: representativity, cancer incidence and mortality in participants and non‐participants , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[64] G. Berglund,et al. Self-administered questionnaire compared with a personal diary for assessment of current use of hormone therapy: an analysis of 16,060 women. , 2000, American journal of epidemiology.
[65] C. Woodworth,et al. Tumor necrosis factor‐α promotes human papillomavirus (HPV) E6/E7 RNA expression and cyclin‐dependent kinase activity in HPV‐immortalized keratinocytes by a ras‐dependent pathway , 2000, Molecular carcinogenesis.
[66] S. Humphries,et al. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.
[67] W. Erl,et al. Effects of Oxidized Low Density Lipoprotein, Lipid Mediators and Statins on Vascular Cell Interactions , 1999, Clinical chemistry and laboratory medicine.
[68] F. Werf,et al. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. , 1998, Circulation.
[69] Julian Peto,et al. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies , 1996, The Lancet.
[70] B E Ainsworth,et al. Comprehensive evaluation of the Minnesota Leisure Time Physical Activity Questionnaire. , 1994, Journal of clinical epidemiology.
[71] Daniel Steinberg,et al. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. , 1988, Archives of internal medicine.
[72] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.